University of Maryland School of Medicine Dean Mark T. Gladwin, MD, along with University of Maryland Medical Center (UMMC) ...

Patients as Partners® in Clinical Research Now Part of Questex’s Fierce Life Sciences Portfolio; First Conference to Put Patients at the Same Level as R&D Executives in a National Event Takes Place in ...

Eligible students can apply via the website, Avance Clinical Diversity in STEM Scholarships, selecting either the APAC or North America intake depending on their region of study. Please direct ...

Some of our most promising biotechs have taken part in a pre yuletide rush of clinical trial updates – and there is much to ...

Today, the Lupus Research Alliance, the world's largest private funder of lupus research, announced the first recipients of ...

Seven scientists with the Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium received another year of ...

UNIONDALE, NY / ACCESS Newswire / December 8, 2025 / Marquis Who’s Who, the trusted biographical authority documenting ...

Out of more than 300 applicants, Ayudando Latinos a Soñar (ALAS) was selected as one of only five organizations in the U.S. to receive a prestigious $200,000 national research grant from the Robert ...

This achievement marks both an academic milestone for the institution and a new chapter in healthcare in southeastern North Carolina. The first cohort represents working parents, first-generation ...

INDIANAPOLIS — Indiana University and pharmaceutical giant Eli Lilly have made official a five-year collaboration in which ...

Foralumab is the only fully human anti-CD3 monoclonal antibody (mAb) currently in clinical development. Immunomodulation by intranasal foralumab represents a novel avenue for the treatment of ...

IMGS-001 is a cytotoxic immune checkpoint inhibitor targeting PD-L1 and PD-L2 and is designed to treat the many "immune-excluded" cancers that are resistant to existing immunotherapies HOUSTON, Dec. 4 ...